Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-06-08, Stock:NVS, The news for the past five days is as follows:
2020-06-01: NEWS1: Novartis' (NVS) Breast Cancer Drug Gets Positive CHMP Opinion.
2020-06-02: NEWS1: AstraZeneca Ranked Most Inventive, Roche Most Innovative.
2020-06-03: NEWS1: Pliant Therapeutics Up 33% on IPO Pricing.NEWS2: Novartis' sBLA for Ofatumumab Gets Extended Review From FDA.NEWS3: The Daily Biotech Pulse: Regulatory Delay For Novartis' Multiple Sclerosis Drug, FSD Gets Nod For COVID-19 Study.
2020-06-04: NEWS1: Pliant Therapeutics Shares Have Climbed 44% Since This Week's IPO.NEWS2: Novartis (NVS) Announces Positive Data From Cosentyx Study.NEWS3: The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic.
2020-06-05: NEWS1: Hope dims for hydroxychloroquine even as medical study detailing the drug’s failure is retracted.NEWS2: Novartis' Asthma Treatment Meets Primary Endpoint in Phase III.NEWS3: Pharma Stock Roundup: LLY Coronavirus Antibody Phase I Study Initiation, FDA Approvals.NEWS4: The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid.

Answer: Decrease